574 related articles for article (PubMed ID: 18476815)
1. Standardized quantification of pulmonary fibrosis in histological samples.
Hübner RH; Gitter W; El Mokhtari NE; Mathiak M; Both M; Bolte H; Freitag-Wolf S; Bewig B
Biotechniques; 2008 Apr; 44(4):507-11, 514-7. PubMed ID: 18476815
[TBL] [Abstract][Full Text] [Related]
2. Quantification of Pulmonary Fibrosis in a Bleomycin Mouse Model Using Automated Histological Image Analysis.
Gilhodes JC; Julé Y; Kreuz S; Stierstorfer B; Stiller D; Wollin L
PLoS One; 2017; 12(1):e0170561. PubMed ID: 28107543
[TBL] [Abstract][Full Text] [Related]
3. Semiquantitative measurement of murine bleomycin-induced lung fibrosis in in vivo and postmortem conditions using microcomputed tomography: correlation with pathologic scores--initial results.
Lee HJ; Goo JM; Kim NR; Kim MA; Chung DH; Son KR; Kim HC; Lee CH; Park CM; Chun EJ; Im JG
Invest Radiol; 2008 Jun; 43(6):453-60. PubMed ID: 18496052
[TBL] [Abstract][Full Text] [Related]
4. Mouse models of bleomycin-induced pulmonary fibrosis.
Walters DM; Kleeberger SR
Curr Protoc Pharmacol; 2008 Mar; Chapter 5():Unit 5.46. PubMed ID: 22294226
[TBL] [Abstract][Full Text] [Related]
5. Modulation of bleomycin-induced pulmonary toxicity in the hamster by the antioxidant amifostine.
Nici L; Santos-Moore A; Kuhn C; Calabresi P
Cancer; 1998 Nov; 83(9):2008-14. PubMed ID: 9806661
[TBL] [Abstract][Full Text] [Related]
6. Evaluating the inhibitory potential of sulindac against the bleomycin-induced pulmonary fibrosis in wistar rats.
Verma R; Brahmankar M; Kushwah L; Suresh B
Environ Toxicol Pharmacol; 2013 Nov; 36(3):769-78. PubMed ID: 23958969
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging for noninvasive assessment of lung fibrosis onset and progression: cross-validation and comparison of different magnetic resonance imaging protocols with micro-computed tomography and histology in the bleomycin-induced mouse model.
Vande Velde G; De Langhe E; Poelmans J; Dresselaers T; Lories RJ; Himmelreich U
Invest Radiol; 2014 Nov; 49(11):691-8. PubMed ID: 24872004
[TBL] [Abstract][Full Text] [Related]
8. Bleomycin-induced fibrosis in pigs: evaluation with CT.
Balazs G; Noma S; Khan A; Eacobacci T; Herman PG
Radiology; 1994 Apr; 191(1):269-72. PubMed ID: 7510895
[TBL] [Abstract][Full Text] [Related]
9. Hydrogen sulfide protects against bleomycin-induced pulmonary fibrosis in rats by inhibiting NF-κB expression and regulating Th1/Th2 balance.
Cao H; Zhou X; Zhang J; Huang X; Zhai Y; Zhang X; Chu L
Toxicol Lett; 2014 Jan; 224(3):387-94. PubMed ID: 24269241
[TBL] [Abstract][Full Text] [Related]
10. Effect of glycosides based standardized fenugreek seed extract in bleomycin-induced pulmonary fibrosis in rats: Decisive role of Bax, Nrf2, NF-κB, Muc5ac, TNF-α and IL-1β.
Kandhare AD; Bodhankar SL; Mohan V; Thakurdesai PA
Chem Biol Interact; 2015 Jul; 237():151-65. PubMed ID: 26093215
[TBL] [Abstract][Full Text] [Related]
11. Deep neural network based histological scoring of lung fibrosis and inflammation in the mouse model system.
Heinemann F; Birk G; Schoenberger T; Stierstorfer B
PLoS One; 2018; 13(8):e0202708. PubMed ID: 30138413
[TBL] [Abstract][Full Text] [Related]
12. Enhanced endogenous bone morphogenetic protein signaling protects against bleomycin induced pulmonary fibrosis.
De Langhe E; Cailotto F; De Vooght V; Aznar-Lopez C; Vanoirbeek JA; Luyten FP; Lories RJ
Respir Res; 2015 Mar; 16(1):38. PubMed ID: 25849157
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulation of experimental pulmonary fibrosis by intravenous immunoglobulin (IVIG).
Molina V; Haj-Yahia S; Solodeev I; Levy Y; Blank M; Shoenfeld Y
Autoimmunity; 2006 Dec; 39(8):711-7. PubMed ID: 17178568
[TBL] [Abstract][Full Text] [Related]
14. Effects of a leukotriene B4 receptor antagonist on bleomycin-induced pulmonary fibrosis.
Izumo T; Kondo M; Nagai A
Eur Respir J; 2009 Dec; 34(6):1444-51. PubMed ID: 19460787
[TBL] [Abstract][Full Text] [Related]
15. Quantification of bleomycin-induced murine lung damage in vivo with micro-computed tomography.
Cavanaugh D; Travis EL; Price RE; Gladish G; White RA; Wang M; Cody DD
Acad Radiol; 2006 Dec; 13(12):1505-12. PubMed ID: 17138119
[TBL] [Abstract][Full Text] [Related]
16. Bleomycin induces strain-dependent alterations in the pattern of epithelial cell-specific marker expression in mouse lung.
Daly HE; Baecher-Allan CM; Barth RK; D'Angio CT; Finkelstein JN
Toxicol Appl Pharmacol; 1997 Feb; 142(2):303-10. PubMed ID: 9070353
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of two mouse models of lung fibrosis induced by intratracheal instillation and intratracheal aerosol administration of bleomycin].
Li W; Hu Y; Yuan W; Li L; Huang W
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Feb; 32(2):221-5. PubMed ID: 22381763
[TBL] [Abstract][Full Text] [Related]
18. Simvastatin attenuates bleomycin-induced pulmonary fibrosis in mice.
Ou XM; Feng YL; Wen FQ; Huang XY; Xiao J; Wang K; Wang T
Chin Med J (Engl); 2008 Sep; 121(18):1821-9. PubMed ID: 19080365
[TBL] [Abstract][Full Text] [Related]
19. [Effects of polydatin on bleomycin-induced pulmonary fibrosis in rats].
Zhang Y; Chen L; Liang B
Zhongguo Zhong Yao Za Zhi; 2011 Dec; 36(24):3528-34. PubMed ID: 22368872
[TBL] [Abstract][Full Text] [Related]
20. Effect of granulocyte colony-stimulating factor on bleomycin-induced acute lung injury and pulmonary fibrosis.
Azoulay E; Herigault S; Levame M; Brochard L; Schlemmer B; Harf A; Delclaux C
Crit Care Med; 2003 May; 31(5):1442-8. PubMed ID: 12771616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
